Dr. Martens PLC Director/PDMR Shareholding

RNS Number : 4344F

Dr. Martens PLC

24 September 2024

 

Dr. Martens plc (the 'Company')

Director/PDMR Shareholding

Notification of Transactions by Directors/Persons Discharging Managerial Responsibility

The Company announces that it has been notified that Andrew Harrison, Independent Non-Executive Director and PDMR, purchased 58,220 ordinary shares of 1 pence each in the Company ('Ordinary Shares') on 24 September 2024 at a price of £0.515279 per Ordinary Share.

The relevant notification, set out below, is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

 

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Andrew Harrison
2	Reason for the notification
a)	Position/status	PDMR (Non-Executive Director)
b)	Initial notification/Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Dr. Martens plc
b)	LEI	213800QPT8YM6NQZPH28
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.515279 58,220
d)	Aggregated information   - Aggregated volume - Price	Single transaction
e)	Date of the transaction	24 September 2024
f)	Place of the transaction	London Stock Exchange (XLON)

 

For further information please contact:

 

Paul Rolling

Assistant Company Secretary

[e-mail]

[phone]

 

Bethany Barnes

Director of Investor Relations

[e-mail]

[phone]

 

                            

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHUSVKRSUUKURR